Larvol Delta - Axalbion-Announces-Positive-Findings-from-Phase-2-Clinical-Study-in-Chronic-Cough-with-AX8-a-Novel-TRPM8-Agonist

AX-8 - Axalbion

https://www.businesswire.com/news/home/20220629005372/en/Axalbion-Announces-Positive-Findings-from-Phase-2-Clinical-Study-in-Chronic-Cough-with-AX-8-a-Novel-TRPM8-Agonist

Jun 29, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next